You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Novo Nordisk Articles
Popular Novo Nordisk Articles
Highly Recommended Novo Nordisk Articles
Send a link to this page to your friends and colleagues.
In July 2005, Novo Nordisk announced the availability of its GlucaGen HypoKit (injectable glucagon of rDNA origin) for the treatment of severe hypoglycemic reactions that may occur in people with insulin-dependent diabetes.
“The GlucaGen HypoKit is fully portable and can be used wherever it is needed, in any setting,” says a spokesperson for Novo Nordisk. The GlucaGen HypoKit is an emergency kit consisting of a syringe prefilled with sterile water for mixing and a vial of GlucaGen powder. The hard-shell, bright orange case provides product protection, requires no refrigeration, and is easily identifiable in an emergency.
“GlucaGen HypoKit has comprehensive picture instructions for the administrator during an emergency situation and holds no danger of overdose,” says Novo Nordisk. “Family members or caregivers should practice and become familiar with the technique of preparing glucagon before an emergency arises. Additionally, GlucaGen HypoKit is safe for use in children.”
Peter Aurup, MD, vice president of clinical development, medical and regulatory affairs at Novo Nordisk, says, “Making GlucaGen available to people living with diabetes in a non-hospital setting addresses a huge unmet medical need because a vast majority of patients on insulin therapy do not currently own a glucagon emergency kit.”
For more information about the GlucaGen HypoKit, contact Novo Nordisk at (800) 727-6500 or visit www.novonordisk-us.com.
Source: Novo Nordisk
Feb 1, 2006
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.